Health ❯ Healthcare ❯ Public Health

HIV Prevention

PrEP Cabotegravir Lenacapavir Injection Lenacapavir PrEP (Profilaxia Pré-Exposição) Federal Funding Long-acting Injection Transgender Care Antiretroviral Medications Clinical Trials

Canada Updates HIV Prevention Guidance, Endorses PrEP on Request

Authors frame the CMAJ update as a tool to expand equitable access after recent increases in HIV diagnoses.

NHS to Roll Out First Long‑Acting HIV Prevention Injection After NICE Green Light

Conitec Begins Review of Injectable HIV PrEP for Brazil's SUS

New Biannual HIV Injection Reduces Infection Risk by 96%

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV